Search research articles
Contact Us
Filters
Showing results (321-330 of 1,603) with videos related to
Page
of 161
Sort By:
The Lancet. Respiratory Medicine
|
December 4, 2014
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
James Walter, Lorraine B Ware, Michael A Matthay
Critical Care Medicine
|
January 15, 1998
Just say NO to inhaled nitric oxide for the acute respiratory distress syndrome
M A Matthay, J F Pittet, C Jayr
Shock (Augusta, Ga.)
|
July 23, 2020
Good Platelets Gone Bad: The Effects of Trauma Patient Plasma on Healthy Platelet Aggregation
Alexander T Fields, Zachary A Matthay, Brenda Nunez-Garcia, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 4, 2006
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
Tokujiro Uchida, Madoka Shirasawa, Lorraine B Ware, et al.
The Lancet. Respiratory Medicine
|
March 24, 2020
Treatment for severe acute respiratory distress syndrome from COVID-19
Michael A Matthay, J Matthew Aldrich, Jeffrey E Gotts
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
January 25, 2011
Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells
Naoko Yamakawa, Tokujiro Uchida, Michael A Matthay, et al.
Critical Care Medicine
|
September 15, 2010
Stem cells in sepsis and acute lung injury
Sushma K Cribbs, Michael A Matthay, Greg S Martin
JAMA Internal Medicine
|
March 10, 2025
Awake Prone Positioning in COVID-19-Is There a New Standard of Care?
Michael A Matthay, Katherine D Wick, Narges Alipanah-Lechner
Clinical Sarcoma Research
|
June 9, 2016
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma
Kieuhoa T Vo, Katherine K Matthay, Steven G DuBois
Chest
|
April 1, 1987
Adult respiratory distress syndrome related to antilymphocyte globulin therapy
N C Dean, W C Amend, M A Matthay
Page
of 161
Search research articles
Search
Showing results (321-330 of 1,603) with videos related to
Sort By:
Page
of 161
The Lancet. Respiratory Medicine
|
December 4, 2014
Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis
James Walter, Lorraine B Ware, Michael A Matthay
Critical Care Medicine
|
January 15, 1998
Just say NO to inhaled nitric oxide for the acute respiratory distress syndrome
M A Matthay, J F Pittet, C Jayr
Shock (Augusta, Ga.)
|
July 23, 2020
Good Platelets Gone Bad: The Effects of Trauma Patient Plasma on Healthy Platelet Aggregation
Alexander T Fields, Zachary A Matthay, Brenda Nunez-Garcia, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 4, 2006
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
Tokujiro Uchida, Madoka Shirasawa, Lorraine B Ware, et al.
The Lancet. Respiratory Medicine
|
March 24, 2020
Treatment for severe acute respiratory distress syndrome from COVID-19
Michael A Matthay, J Matthew Aldrich, Jeffrey E Gotts
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
January 25, 2011
Proteolytic release of the receptor for advanced glycation end products from in vitro and in situ alveolar epithelial cells
Naoko Yamakawa, Tokujiro Uchida, Michael A Matthay, et al.
Critical Care Medicine
|
September 15, 2010
Stem cells in sepsis and acute lung injury
Sushma K Cribbs, Michael A Matthay, Greg S Martin
JAMA Internal Medicine
|
March 10, 2025
Awake Prone Positioning in COVID-19-Is There a New Standard of Care?
Michael A Matthay, Katherine D Wick, Narges Alipanah-Lechner
Clinical Sarcoma Research
|
June 9, 2016
Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma
Kieuhoa T Vo, Katherine K Matthay, Steven G DuBois
Chest
|
April 1, 1987
Adult respiratory distress syndrome related to antilymphocyte globulin therapy
N C Dean, W C Amend, M A Matthay
Page
of 161